Days Sales in Receivables: The average number of days it takes to collect outstanding receivable amounts from customers. Calculated as: Number of Days in Period / Receivable Turnover
Puma Biotechnology, Inc. (PBYI) had Days Sales in Receivables of 49.24 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$46.01M |
|
$2.97M |
|
$10.56M |
|
$35.45M |
|
$42.02M |
|
$3.98M |
|
$-0.72M |
|
$3.27M |
|
$3.27M |
|
$2.97M |
|
$2.97M |
|
$2.97M |
|
$2.97M |
|
$3.98M |
|
$6.78M |
|
49.60M |
|
49.91M |
|
$0.06 |
|
$0.06 |
|
| Balance Sheet Financials | |
$132.51M |
|
$0.47M |
|
$63.67M |
|
$196.18M |
|
$86.66M |
|
$10.65M |
|
$12.41M |
|
$99.07M |
|
$97.11M |
|
$48.41M |
|
$97.11M |
|
49.62M |
|
| Cash Flow Statement Financials | |
$3.61M |
|
$1.53M |
|
$-11.33M |
|
$71.31M |
|
$65.12M |
|
$-6.19M |
|
$2.03M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.53 |
|
-- |
|
-- |
|
0.10 |
|
0.58 |
|
77.06% |
|
8.66% |
|
8.66% |
|
-- |
|
7.10% |
|
6.46% |
|
$3.55M |
|
-- |
|
-- |
|
-- |
|
0.23 |
|
1.21 |
|
1.83 |
|
|
Days Sales in Receivables |
49.24 |
3.06% |
|
6.14% |
|
1.52% |
|
2.76% |
|
$1.96 |
|
$0.07 |
|
$0.07 |
|